XV
Xvivo Perfusion AB (publ)
XVIPF · OTC
$30.95 +0.00% (+$0.00)
Market Cap 9.51B kr
P/E Ratio 107.72x
Div. Yield -
ROE 5.37%
Bulios Fair Price
$21.59
30.2% downside
Trenutna cena
$30.95
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica XVIPF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
0 /100
Expensive P/E 107.72x
P/FCF 67.06x
EV/EBITDA 51.78x
Growth
83 /100
Growing EPS growth 8.87%
Book val. growth 13.81%
Rev. growth 24.95%
Profitability
76 /100
Strong Gross margin 66.41%
FCF margin 15.92%
Net margin 9.91%
Quality
77 /100
Excellent ROIC 30.36%
Asset turnover 3.43x
ROE 5.37%
Debt
100 /100
Low Debt/Equity 0.06x
Net debt/EBITDA -0.10x
Current ratio 3.86x
Stability
35 /100
Moderate Beta 1.46x
Profitable years 5
Rev. volatility 24.59%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o XVIPF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Christoffer Rosenblad
Employees
210
Headquarters
Mölndal
Prihajajoči dogodki
22 OKT.
Earnings
Upcoming earnings report